At the opposite, liver-specific seipin deficiency (42, 43) does not induce liver steatosis nor insulin resistance, discarding an autonomous role of seipin in the hepatocyte at the origin of the liver complications reported in BSCL2 patients. Here, BSCL2 is linked to fatty liver disease.